Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
Harvard Eye Associates [0]   
[20/02/2024]

Harvard Eye Associates : Harvard Eye Associates Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma

iDose® TR helps patients with glaucoma take longterm control of high eye pressureLAGUNA HILLS, CA / ACCESSWIRE / February 20, 2024 / Harvard Eye Associates is proud to announce the availability of iDose® TR travoprost intraocular implant 75 mcg. iDose® TR is a new, FDAapproved treatment that is designed to provide longduration, continuous drug therapy directly inside the eye,... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de Harvard...